Counterfeit
Pharmaceutical companies struggle against counterfeit drugs that are flourishing not only online but even in pharmacies and hospitals. These drugs endanger public health as well as the manufacturers reputation.
To protect our products against counterfeiting and parallel import we have developed several measures. These include complying with the pack serialization requirements set out by the various markets, standardizing prices across the region, close monitoring of sales and forecasts with the appointed distributors and have established internal Standard Operating Procedures to report such cases.
Moreover, we embrace close collaboration and cooperation with our internal stakeholders, the governmental authorities, health professionals and the consumers to combat counterfeiting.